243 related articles for article (PubMed ID: 36635907)
1. Nanocarrier Based Delivery of Berberine: A Critical Review on Pharmaceutical and Preclinical Characteristics of the Bioactive.
Khan MJ; Hafeez A; Siddiqui MA
Curr Pharm Biotechnol; 2023; 24(11):1449-1464. PubMed ID: 36635907
[TBL] [Abstract][Full Text] [Related]
2. Expatiating the Pharmacological and Nanotechnological Aspects of the Alkaloidal Drug Berberine: Current and Future Trends.
Behl T; Singh S; Sharma N; Zahoor I; Albarrati A; Albratty M; Meraya AM; Najmi A; Bungau S
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744831
[TBL] [Abstract][Full Text] [Related]
3. Nano strategies for berberine delivery, a natural alkaloid of Berberis.
Mirhadi E; Rezaee M; Malaekeh-Nikouei B
Biomed Pharmacother; 2018 Aug; 104():465-473. PubMed ID: 29793179
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory efficacy of Berberine Nanomicelle for improvement of cerebral ischemia: formulation, characterization and evaluation in bilateral common carotid artery occlusion rat model.
Azadi R; Mousavi SE; Kazemi NM; Yousefi-Manesh H; Rezayat SM; Jaafari MR
BMC Pharmacol Toxicol; 2021 Oct; 22(1):54. PubMed ID: 34600570
[TBL] [Abstract][Full Text] [Related]
5. Fabrication, characterization and optimization of berberine-loaded PLA nanoparticles using coaxial electrospray for sustained drug release.
Ghaffarzadegan R; Khoee S; Rezazadeh S
Daru; 2020 Jun; 28(1):237-252. PubMed ID: 32307652
[TBL] [Abstract][Full Text] [Related]
6. Nano-based delivery systems for berberine: A modern anti-cancer herbal medicine.
Majidzadeh H; Araj-Khodaei M; Ghaffari M; Torbati M; Ezzati Nazhad Dolatabadi J; Hamblin MR
Colloids Surf B Biointerfaces; 2020 Oct; 194():111188. PubMed ID: 32540763
[TBL] [Abstract][Full Text] [Related]
7. Micro- and Nanoencapsulated Hybrid Delivery System (MNEHDS): A Novel Approach for Colon-Targeted Oral Delivery of Berberine.
Zhang L; Li M; Zhang G; Gao C; Wang S; Zhang T; Ma C; Wang L; Zhu Q
Mol Pharm; 2021 Apr; 18(4):1573-1581. PubMed ID: 33629860
[TBL] [Abstract][Full Text] [Related]
8. In vivo anti-apoptosis activity of novel berberine-loaded chitosan nanoparticles effectively ameliorates osteoarthritis.
Zhou Y; Liu SQ; Peng H; Yu L; He B; Zhao Q
Int Immunopharmacol; 2015 Sep; 28(1):34-43. PubMed ID: 26002585
[TBL] [Abstract][Full Text] [Related]
9. Nanoformulation and Evaluation of Oral Berberine-Loaded Liposomes.
Duong TT; Isomäki A; Paaver U; Laidmäe I; Tõnisoo A; Yen TTH; Kogermann K; Raal A; Heinämäki J; Pham TM
Molecules; 2021 Apr; 26(9):. PubMed ID: 33946815
[TBL] [Abstract][Full Text] [Related]
10. Self-nanoemulsifying system improves oral absorption and enhances anti-acute myeloid leukemia activity of berberine.
Li J; Yang L; Shen R; Gong L; Tian Z; Qiu H; Shi Z; Gao L; Sun H; Zhang G
J Nanobiotechnology; 2018 Oct; 16(1):76. PubMed ID: 30290822
[TBL] [Abstract][Full Text] [Related]
11. Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis.
Deng J; Wu Z; Zhao Z; Wu C; Yuan M; Su Z; Wang Y; Wang Z
Int J Nanomedicine; 2020; 15():3937-3951. PubMed ID: 32581538
[TBL] [Abstract][Full Text] [Related]
12. Dual-functional Brij-S20-modified nanocrystal formulation enhances the intestinal transport and oral bioavailability of berberine.
Xiong W; Sang W; Linghu KG; Zhong ZF; Cheang WS; Li J; Hu YJ; Yu H; Wang YT
Int J Nanomedicine; 2018; 13():3781-3793. PubMed ID: 29988733
[TBL] [Abstract][Full Text] [Related]
13. Berberine-loaded liposomes for oral delivery: Preparation, physicochemical characterization and in-vivo evaluation in an endogenous hyperlipidemic animal model.
Duong TT; Yen TTH; Nguyen LT; Nguyen TD; Nguyen TQ; Nghiem TH; Pham HT; Raal A; Heinämäki J; Pham TM
Int J Pharm; 2022 Mar; 616():121525. PubMed ID: 35104597
[TBL] [Abstract][Full Text] [Related]
14. PEG-lipid-PLGA hybrid nanoparticles loaded with berberine-phospholipid complex to facilitate the oral delivery efficiency.
Yu F; Ao M; Zheng X; Li N; Xia J; Li Y; Li D; Hou Z; Qi Z; Chen XD
Drug Deliv; 2017 Nov; 24(1):825-833. PubMed ID: 28509588
[TBL] [Abstract][Full Text] [Related]
15. Berberine Nanoencapsulation Attenuates Hallmarks of Scoplomine Induced Alzheimer's-Like Disease in Rats.
Saleh SR; Abady MM; Nofal M; Yassa NW; Abdel-Latif MS; Nounou MI; Ghareeb DA; Abdel-Monaem N
Curr Rev Clin Exp Pharmacol; 2021; 16(2):139-154. PubMed ID: 32598269
[TBL] [Abstract][Full Text] [Related]
16. Research progress on berberine with a special focus on its oral bioavailability.
Liu CS; Zheng YR; Zhang YF; Long XY
Fitoterapia; 2016 Mar; 109():274-82. PubMed ID: 26851175
[TBL] [Abstract][Full Text] [Related]
17. Characterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticles.
Xue M; Yang MX; Zhang W; Li XM; Gao DH; Ou ZM; Li ZP; Liu SH; Li XJ; Yang SY
Int J Nanomedicine; 2013; 8():4677-87. PubMed ID: 24353417
[TBL] [Abstract][Full Text] [Related]
18. Berberine-loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro.
Paudel KR; Mehta M; Yin GHS; Yen LL; Malyla V; Patel VK; Panneerselvam J; Madheswaran T; MacLoughlin R; Jha NK; Gupta PK; Singh SK; Gupta G; Kumar P; Oliver BG; Hansbro PM; Chellappan DK; Dua K
Environ Sci Pollut Res Int; 2022 Jul; 29(31):46830-46847. PubMed ID: 35171422
[TBL] [Abstract][Full Text] [Related]
19. In Vitro and In Vivo Evaluations of Berberine-Loaded Microparticles Filled In-House 3D Printed Hollow Capsular Device for Improved Oral Bioavailability.
Choudhury D; Jala A; Murty US; Borkar RM; Banerjee S
AAPS PharmSciTech; 2022 Mar; 23(4):89. PubMed ID: 35296955
[TBL] [Abstract][Full Text] [Related]
20. A patent review of berberine and its derivatives with various pharmacological activities (2016-2020).
Kong Y; Li L; Zhao LG; Yu P; Li DD
Expert Opin Ther Pat; 2022 Feb; 32(2):211-223. PubMed ID: 34455891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
